VINDIS, David, Martin HUTYRA, Daniel SANAK, Michal KRAL, Eva CECHAKOVA, Simona LITTNEROVÁ, Tomas ADAM, Jan PRECEK, Stepan HUDEC, Marketa JECMENOVA a Milos TABORSKY. Patent Foramen Ovale and the Risk of Cerebral Infarcts in Acute Pulmonary Embolism-A Prospective Observational Study. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. AMSTERDAM: ELSEVIER SCIENCE BV, 2018, roč. 27, č. 2, s. 357-364. ISSN 1052-3057. Dostupné z: https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.004.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Patent Foramen Ovale and the Risk of Cerebral Infarcts in Acute Pulmonary Embolism-A Prospective Observational Study
Autoři VINDIS, David (203 Česká republika), Martin HUTYRA (203 Česká republika, garant), Daniel SANAK (203 Česká republika), Michal KRAL (203 Česká republika), Eva CECHAKOVA (203 Česká republika), Simona LITTNEROVÁ (203 Česká republika, domácí), Tomas ADAM (203 Česká republika), Jan PRECEK (203 Česká republika), Stepan HUDEC (203 Česká republika), Marketa JECMENOVA (203 Česká republika) a Milos TABORSKY (203 Česká republika).
Vydání JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, AMSTERDAM, ELSEVIER SCIENCE BV, 2018, 1052-3057.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30103 Neurosciences
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 1.646
Kód RIV RIV/00216224:14110/18:00104069
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.004
UT WoS 000419585800019
Klíčová slova anglicky Pulmonary embolism; patent foramen ovale; brain infarction; echocardiography; brain magnetic resonance imaging
Štítky 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 10. 2. 2019 17:15.
Anotace
Background: Pulmonary embolism (PE) is associated with a risk of consecutive paradoxical embolism with brain infarction through a patent foramen ovale (PFO). The aims of this study were to assess the rate of new ischemic brain lesions (IBLs) using magnetic resonance imaging (MRI) during a 12-month follow-up period with anticoagulation and to evaluate the potential relationship with the presence of PFO on transesophageal echocardiography (TEE). Subjects and Methods: Seventy-eight patients with acute PE underwent baseline contrast TEE with brain MRI. After the 12-month follow-up, 58 underwent brain MRI. The rates of MRI documenting new IBLs were measured based on the presence of PFO. Results: PFO was detected in 31 patients (39.7%). At baseline MRI, IBL was present in 39 of 78 patients (50%). The presence of IBL was not significantly higher in patients with PFO than in patients without PFO (20 [64.5% patients with PFO] versus 19 [40.4% without PFO] of 39 patients with baseline IBL, P = .063). At the follow-up MRI, in the group with new IBL (9 of 58 patients, 15.5%), the number of patients with PFO was significantly higher than that without PFO (7 [33.3%] versus 2 [5.4%], P = .008). PFO was identified as an independent predictor of new IBL (odds ratio 4.6 [1.6-47.4], P = .008). Conclusions: The presence of PFO was associated with new IBL in patients with PE. These patients are at a higher risk of ischemic stroke despite effective anticoagulation therapy.
VytisknoutZobrazeno: 28. 7. 2024 13:14